3 Medical Shifts in 2026: Kidney Protection, Metabolism & Longevity | Live AMA

The old CKD playbook -- bland diet, blood pressure pill, hope for the best -- is dead. In this live AMA, Dr. Sean Hashmi breaks down three major shifts happening right now in kidney and metabolic medicine heading into 2026.

The Kidney Shift: The FDA just approved Ozempic for kidney protection in type 2 diabetes (the FLOW trial), plus new precision immunotherapy for IgA nephropathy and early data on kidney tissue regeneration.

The Metabolic Shift: New evidence on intermittent fasting, meal timing, GLP-1 effects on the brain and muscle, and why resistance training is non-negotiable if you're on these drugs.

The Longevity Shift: How SGLT2 inhibitors may double as longevity drugs, the science of biological aging vs. chronological age, and what senolytic research means for kidney patients.

Plus a full live Q&A covering potassium myths, plant-based diets for CKD, alcohol and kidney health, oral vs. injectable GLP-1s, protein powders, green smoothies, and more.

Your action plan: Ask your doctor about GLP-1s and SGLT2 inhibitors for kidney protection. Count 30 plant types this week. Keep your eating window under 12 hours. Lift heavy things.

Dr. Sean Hashmi is a board-certified nephrologist and obesity medicine specialist. New evidence-based videos every week.

Subscribe: youtube.com/@SeanHashmiMDNewsletter: selfprinciple.org/newsletterInstagram: @seanhashmimd

Medical Disclaimer: This episode is for educational purposes only and is not medical advice, diagnosis, or treatment. Always consult your healthcare provider before making changes to your health routine. The views expressed are Dr. Hashmi's personal professional opinions and do not represent any employer or affiliated organization.

#KidneyHealth #GLP1 #ChronicKidneyDisease #EvidenceBasedMedicine #SeanHashmiMD